Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / VRNA - Verona Pharma granted FDA review for COPD therapy

VRNA - Verona Pharma granted FDA review for COPD therapy

September, 11 2023 09:18 AM Verona Pharma plc

2023-09-11 09:18:57 ET

More on Verona

Seeking Alpha’s Quant Rating on Verona Pharma
Historical earnings data for Verona Pharma
Financial information for Verona Pharma
Verona Pharma: De-Risked COPD Biotech Play, Approval Likely Coming Soon
Verona Pharma: Financial Health And COPD Market Impact 2024
Verona Pharma: Targeting The Large COPD Market
Verona Pharma plc. ( VRNA ) Q2 2023 Earnings Call Transcript

For further details see:

Verona Pharma granted FDA review for COPD therapy

Stock Information

Company Name:	Verona Pharma plc
Stock Symbol:	VRNA
Market:	NASDAQ
Website:	veronapharma.com

VRNA VRNA Quote VRNA Short VRNA News VRNA Articles VRNA Message Board

Get VRNA Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.